Nervgen Pharma Corp (NGEN.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 6,171 | 6,469 | 6,035 | 6,806 | 7,156 |
| Operating Income | -6,171 | -6,469 | -6,035 | -6,806 | -7,156 |
| Other Income | 2,015 | -2,635 | 2,087 | -1,803 | 1,931 |
| Pre-tax Income | -4,156 | -9,104 | -3,948 | -8,609 | -5,226 |
| Net Income Continuous | -4,156 | -9,104 | -3,948 | -8,609 | -5,226 |
| Net Income | $-4,156 | $-9,104 | $-3,948 | $-8,609 | $-5,226 |
| EPS Basic Total Ops | -0.06 | -0.13 | -0.06 | -0.13 | -0.07 |
| EPS Basic Continuous Ops | -0.06 | -0.13 | -0.06 | -0.13 | -0.07 |
| EPS Diluted Total Ops | -0.06 | -0.13 | -0.06 | -0.13 | -0.07 |
| EPS Diluted Continuous Ops | -0.06 | -0.13 | -0.06 | -0.13 | -0.07 |
| EBITDA(a) | $-6,157 | $-6,455 | $-6,021 | $-6,790 | $-7,142 |